Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Do | NewGenIVF Group Limited: NewGen Issues Clarification on Press Release Titled "NewGen Receives Continued Nasdaq Listing Approval and Announces New Business Development Director" dated February 20, 2025 | 2 | GlobeNewswire (USA) | ||
NEWGENIVF GROUP Aktie jetzt für 0€ handeln | |||||
Do | Pre-market Movers: WORK Medical Technology, Xos, Inc., NewGenIvf Group, Herbalife, PodcastOne | 387 | AFX News | BEIJING (dpa-AFX) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 08.15 A.M. ET).In the Green WORK Medical Technology Group LTD (WOK) is up over... ► Artikel lesen | |
Do | NewGenIvf Group receives approval for continued Nasdaq listing; shares rise | 3 | Seeking Alpha | ||
Do | NewGenIvf Says Granted Request For Continued Listing On Nasdaq | 2 | RTTNews | ||
Do | NewGenIVF Group Limited: NewGen Receives Continued Nasdaq Listing Approval and Announces New Business Development Director | 84 | GlobeNewswire (Europe) | Company Granted Request to Continue its Listing on NasdaqAppoints Thorain Ko to Lead Business Development Initiatives BANGKOK, Feb. 20, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF)... ► Artikel lesen | |
Do | NewGenIvf Group Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
Mi | Pre-market Movers: Sintx Technologies, Cycurion, OSR Holdings, ReShape Lifesciences, NewGenIvf Group | 374 | AFX News | BEIJING (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 07.35 A.M. ET).In the Green Sintx Technologies, Inc. (SINT) is up over 87%... ► Artikel lesen | |
13.02. | NIVF-Aktie erreicht 52-Wochen-Tief bei 1,85 US-Dollar | - | Investing.com Deutsch | ||
31.01. | NewGenIvf to execute reverse stock split | 1 | Seeking Alpha | ||
31.01. | NewGenIVF Group Limited: NewGen Announces Reverse Stock Split | 141 | GlobeNewswire (Europe) | BANGKOK, Jan. 31, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) ("NewGen" or the "Company"), a comprehensive fertility services provider in Asia helping couples and individuals obtain... ► Artikel lesen | |
31.01. | NewGenIvf Group Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
21.01. | NewGenIVF Group Limited: NewGen Announces Strategic Acquisition of MicroSort Reproductive Technology | 127 | GlobeNewswire (Europe) | The technology, which will be acquired for US$5 million, allows for the separation of X and Y chromosome-bearing sperm cells MicroSort offers several advantages for those seeking reproductive assistance... ► Artikel lesen | |
21.01. | NewGenIvf Group Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
13.01. | NewGenIVF Group Limited: NewGen Launches Innovative Lifetime Egg Freezing Service to Address Growing Market Need in Asia | 4 | GlobeNewswire (USA) | ||
23.12.24 | NewGenIVF Group Limited: NewGen Progresses Reverse Merger Plans with Engagement of Legal Teams and Updated Timeline | 356 | GlobeNewswire (Europe) | BANGKOK, Dec. 23, 2024 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) ("NewGen" or the "Company") today announced that both parties involved in the previously announced reverse merger... ► Artikel lesen | |
12.12.24 | NIVF-Aktie erreicht 52-Wochen-Tief bei 0,31 US-Dollar | 2 | Investing.com Deutsch | ||
11.12.24 | Why Is Fertility Services Provider NewGenIvf Stock Rocketing On Wednesday? | 1 | Benzinga.com | ||
11.12.24 | NewGenIVF Group Limited: NewGen Signs Binding Term Sheet for Reverse Merger with European Wellness Investment Holdings | 128 | GlobeNewswire (Europe) | US$452 million transaction at deemed price of US$3.20 per NewGen share Increased market capitalization and visibility will support NewGen's continued listing on the Nasdaq Global Market Proposed... ► Artikel lesen | |
05.12.24 | NewGenIvf Group Ltd - F-1/A, Registration statement for certain foreign private issuers | - | SEC Filings | ||
03.12.24 | NewGenIvf Group Ltd - 6-K, Report of foreign issuer | - | SEC Filings |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
SERNOVA BIOTHERAPEUTICS | 0,138 | +3,75 % | XETR NEW INSTRUMENTS AVAILABLE ON XETRA - 13.02.2025 | Das Instrument PSH0 CA81752F1062 SERNOVA BIOTHERAPEUTICS EQUITY hat seinen ersten Handelstag am 13.02.2025: CONTINUOUS TRADING WITH AUCTIONS, PAG NAM0, SettlCurr EUR, CCP Y
The instrument PSH0 CA81752F1062... ► Artikel lesen | |
ATOSSA THERAPEUTICS | 0,790 | -7,49 % | Atossa Therapeutics, Inc. (NASDAQ:ATOS) Sees Significant Growth in Short Interest | ||
PING AN HEALTHCARE | 1,175 | -0,17 % | PA GOODDOCTOR (01833): DISCLOSURE OF DEALINGS UNDER RULE 22 OF THE TAKEOVERS CODE | ||
MOUNTAIN VALLEY MD | 0,010 | 0,00 % | Mountain Valley MD Holdings Inc: Mountain Valley hopes for continued growth in 2025 | ||
CO-DIAGNOSTICS | 0,675 | -0,74 % | Co-Diagnostics, Inc. - 8-K, Current Report | ||
CYTOSORBENTS | 1,158 | +6,24 % | CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2024 Product Revenue | Fourth quarter product revenue growth estimated at 22% to 25% year-over-year Fourth quarter gross margin estimated to improve to approximately 70% Management will host in-person investor... ► Artikel lesen | |
VERU | 0,542 | -1,63 % | Veru Inc. Direktor Michael Rankowitz erwirbt Stammaktien im Wert von 84.350 US-Dollar | ||
TEMPEST THERAPEUTICS | 0,865 | +4,92 % | Tempest Therapeutics: Tempest Granted Fast Track Designation from the U.S. Food and Drug Administration for Amezalpat to Treat Patients with Hepatocellular Carcinoma | Fast Track Designation highlights potential of amezalpat to address unmet need for patients with HCC Amezalpat builds momentum with both Fast Track and Orphan Drug Designations BRISBANE, Calif.... ► Artikel lesen | |
VOLITIONRX | 0,561 | -8,94 % | VolitionRx Limited Announces Third Quarter 2024 Financial Results and Business Update | Conference call to discuss financial and operational results scheduled for
Friday, November 15 at 8:30 a.m. U.S. Eastern Time
HENDERSON, Nev., Nov. 14, 2024... ► Artikel lesen | |
EKSO BIONICS | 0,550 | +5,36 % | Ekso Bionics Holdings Aktie: Droht der Durchbruch zu scheitern? | Die Ekso Bionics Holdings verzeichnete am 22. Februar 2025 einen Kursrückgang von 1,44 Prozent auf 0,5525 USD. Der Hersteller von medizinischen Exoskeletten steht kurz vor der Veröffentlichung seiner... ► Artikel lesen | |
IMUNON | 0,850 | -2,30 % | Imunon, Inc.: IMUNON Announces Translational Data from Phase 1/2 OVATION 2 Study of IMNN-001 in Advanced Ovarian Cancer | Data reinforce dose-dependent mechanism with IMNN-001 100mg/m2 dose associated with 20% increase in IL-12 levels compared to 79mg/m2 dose Results from OVATION 2 Study continue to validate TheraPlas®... ► Artikel lesen | |
BEYOND AIR | 0,324 | -4,14 % | Beyond Air COO Michael Gaul erwirbt Stammaktien im Wert von 2.293 US-Dollar | ||
AVINGER | 0,340 | -6,08 % | Avinger, Inc.: Avinger Reports Third Quarter 2024 Results | Lower Operating Cost Profile Drives Improved Productivity, Increased Gross Margin REDWOOD CITY, CA / ACCESSWIRE / November 7, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company... ► Artikel lesen | |
NOVACYT | 0,600 | -1,32 % | Novacyt S.A. - IVDR accreditation for Yourgene QST*R Base assay | ||
AROVELLA THERAPEUTICS | 0,120 | 0,00 % | XFRA E4NA: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILAROVELLA THERAPEUTICS... ► Artikel lesen |